Jo S Stenehjem

Dr Stenehjem holds a tenured researcher position at the Section of Etiology, Department of Research at the Cancer Registry of Norway. His research is mainly focused on lifestyle and occupational factors’ relation to cancer risk.

Dr Stenehjem holds BSc and MSc degrees in physiology and epidemiology from the Norwegian University of Science and Technology and the University of Verona (Italy). He obtained a PhD in epidemiology from the University of Oslo (Norway) in 2014, entitled ”Cancer incidence and occupational exposure in offshore oil industry workers”.

Dr Stenehjem was a Leiv Eiriksson Scholar and visiting predoctoral fellow at the US National Cancer Institute (MD, USA) in 2012, and was awarded a Fulbright Scholarship to visit the Department of Epidemiology at Geisel School of Medicine, Dartmouth College (NH, USA) during the spring 2019.

He conducted his postdoctoral training at the Cancer Registry of Norway’s Department of Research and at the Department of Oncology at Oslo University Hospital, focusing his research on lifestyle and occupational factors’ relation to cancer risk, and how lifestyle factors and cancer treatment affect pulmonary function and exercise capacity among cancer survivors.

Dr Stenehjem has showed a particular interest in epidemiological study design and methods, and has throughout his career put weight on improving his methodological and analytical skills.

Projects

The offshore cohort

Vitamin D, obesity and cutaneous malignant melanoma

Prescribed drugs and cutaneous melanoma

 

Selected publications

Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Ghiasvand R, Larsen IK, Green AC, Veierød MB, Robsahm TE (2020)
Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study
Clin Epidemiol, 12, 1389-1401
DOI 10.2147/CLEP.S269446, PubMed 33376408

Stenehjem JS, Støer NC, Ghiasvand R, Grimsrud TK, Babigumira R, Rees JR, Nilsen LT, Johnsen B, Thorsby PM, Veierød MB, Robsahm TE (2020)
Prediagnostic serum 25-hydroxyvitamin D and melanoma risk
Sci Rep, 10 (1), 20129
DOI 10.1038/s41598-020-77155-2, PubMed 33208828

Stenehjem JS, Babigumira R, Hosgood HD, Veierød MB, Samuelsen SO, Bråtveit M, Kirkeleit J, Rothman N, Lan Q, Silverman DT, Friesen MC, Robsahm TE, Kjærheim K, Andreassen BK, Shala NK, Liu FC, Strand LÅ, Grimsrud TK (2020)
Cohort Profile: The Norwegian Offshore Petroleum Workers (NOPW) Cohort
Int J Epidemiol (in press)
DOI 10.1093/ije/dyaa107, PubMed 32879941

Robsahm TE, Stenehjem JS, Berge LAM, Veierød MB (2020)
Prevalence of Indoor Tanning Among Teenagers in Norway Before and After Enforcement of Ban for Ages Under 18 Years
Acta Derm Venereol, 100 (8), adv00127
DOI 10.2340/00015555-3482, PubMed 32285136

Hektoen HH, Robsahm TE, Andreassen BK, Stenehjem JS, Axcrona K, Mondul A, Gislefoss RE (2020)
Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway
Cancer Med, 9 (12), 4420-4432
DOI 10.1002/cam4.3060, PubMed 32319230

Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Furu K, Juzeniene A, Roscher I, Larsen IK, Green AC, Veierød MB, Robsahm TE (2020)
Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study
Clin Epidemiol, 12, 193-202
DOI 10.2147/CLEP.S241249, PubMed 32110111

 

All publications